Reduced glucose utilization underlies seizure protection with dietary therapy in epileptic EL mice

Epilepsy and Behavior

Volumn 39, Issue , 2014, Pages 48-54

  Meidenbauer, Joshua J ^a   Roberts, Mary F ^a  

^a BOSTON COLLEGE   (United States)

Author keywords

2 Deoxy d glucose (2 DG); Calorie restriction; Epilepsy; Ketogenic diet; Ketone bodies

Indexed keywords

3 HYDROXYBUTYRIC ACID; AMINO ACID; DEOXYGLUCOSE; DRINKING WATER; GLUCOSE; GLUTAMATE DECARBOXYLASE; KETONE;

4 AMINOBUTYRIC ACID BRAIN LEVEL; ANIMAL EXPERIMENT; ARTICLE; BODY WEIGHT; BRAIN METABOLISM; CALORIC RESTRICTION; CONTROLLED STUDY; FEMALE; FLUID INTAKE; GENERALIZED EPILEPSY; GLUCOSE BLOOD LEVEL; GLUCOSE INTAKE; GLUCOSE UTILIZATION; KETOGENIC DIET; MOUSE; NONHUMAN; PROTON NUCLEAR MAGNETIC RESONANCE; SEIZURE SUSCEPTIBILITY; WEIGHT REDUCTION; ANIMAL; BRAIN; DIET THERAPY; DISEASE MODEL; EPILEPSY; METABOLISM; SEIZURES;

3-HYDROXYBUTYRIC ACID; ANIMALS; BRAIN; CALORIC RESTRICTION; DISEASE MODELS, ANIMAL; EPILEPSY; FEMALE; GLUCOSE; KETOGENIC DIET; MICE; SEIZURES;

EID: 84907204998     PISSN: 15255050     EISSN: 15255069     Source Type: Journal    
DOI: 10.1016/j.yebeh.2014.08.007     Document Type: Article

References (39)

1. Neal E.G., Chaffe H., Schwartz R.H., Lawson M.S., Edwards N., Fitzsimmons G., et al. The ketogenic diet for the treatment of childhood epilepsy: a randomised controlled trial. Lancet Neurol 2008, 7:500-506.
2. Hartman A.L., Rubenstein J.E., Kossoff E.H. Intermittent fasting: a "new" historical strategy for controlling seizures?. Epilepsy Res 2013, 104:275-279.
3. Yuen A.W., Sander J.W. Rationale for using intermittent calorie restriction as a dietary treatment for drug resistant epilepsy. Epilepsy Behav 2014, 33C:110-114.
4. Kossoff E.H., Rowley H., Sinha S.R., Vining E.P. A prospective study of the modified Atkins diet for intractable epilepsy in adults. Epilepsia 2008, 49:316-319.
5. Mantis J.G., Centeno N.A., Todorova M.T., McGowan R., Seyfried T.N. Management of multifactorial idiopathic epilepsy in EL mice with caloric restriction and the ketogenic diet: role of glucose and ketone bodies. Nutr Metab 2004, 1:11.
6. Greene A.E., Todorova M.T., McGowan R., Seyfried T.N. Caloric restriction inhibits seizure susceptibility in epileptic EL mice by reducing blood glucose. Epilepsia 2001, 42:1371-1378.
7. Bough K.J., Schwartzkroin P.A., Rho J.M. Calorie restriction and ketogenic diet diminish neuronal excitability in rat dentate gyrus in vivo. Epilepsia 2003, 44:752-760.
8. Zuccoli G., Marcello N., Pisanello A., Servadei F., Vaccaro S., Mukherjee P., et al. Metabolic management of glioblastoma multiforme using standard therapy together with a restricted ketogenic diet: case report. Nutr Metab 2010, 7:33.
9. Meidenbauer J.J., Ta N., Seyfried T.N. Influence of a ketogenic diet, fish-oil, and calorie restriction on plasma metabolites and lipids in C57BL/6J mice. Nutr Metab 2014, 11:23.
10. Hartman A.L., Zheng X., Bergbower E., Kennedy M., Hardwick J.M. Seizure tests distinguish intermittent fasting from the ketogenic diet. Epilepsia 2010, 51:1395-1402.
11. Greene A.E., Todorova M.T., Seyfried T.N. Perspectives on the metabolic management of epilepsy through dietary reduction of glucose and elevation of ketone bodies. J Neurochem 2003, 86:529-537.
12. Kossoff E.H., Rho J.M. Ketogenic diets: evidence for short- and long-term efficacy. Neurotherapeutics 2009, 6:406-414.
13. Todorova M.T., Burwell T.J., Seyfried T.N. Environmental risk factors for multifactorial epilepsy in EL mice. Epilepsia 1999, 40:1697-1707.
14. Suzuki J. Paroxysmal discharges in the electroencephalogram of the El mouse. Experientia 1976, 32:336-338.
15. Meidenbauer J.J., Mantis J.G., Seyfried T.N. The EL mouse: a natural model of autism and epilepsy. Epilepsia 2011, 52:347-357.
16. Todorova M.T., Tandon P., Madore R.A., Stafstrom C.E., Seyfried T.N. The ketogenic diet inhibits epileptogenesis in EL mice: a genetic model for idiopathic epilepsy. Epilepsia 2000, 41:933-940.
17. Nagatomo I., Akasaki Y., Nagase F., Nomaguchi M., Takigawa M. Relationships between convulsive seizures and serum and brain concentrations of phenobarbital and zonisamide in mutant inbred strain EL mouse. Brain Res 1996, 731:190-198.
18. Mantis J.G., Meidenbauer J.J., Zimick N.C., Centeno N.A., Seyfried T.N. Glucose reduces the anticonvulsant effects of the ketogenic diet in EL mice. Epilepsy Res 2014, 108:1137-1144.
19. Gasior M., Yankura J., Hartman A.L., French A., Rogawski M.A. Anticonvulsant and proconvulsant actions of 2-deoxy-d-glucose. Epilepsia 2010, 51:1385-1394.
20. Todorova M.T., Dangler C.A., Drage M.G., Sheppard B.J., Fox J.G., Seyfried T.N. Sexual dysfunction and sudden death in epileptic male EL mice: inheritance and prevention with the ketogenic diet. Epilepsia 2003, 44:25-31.
21. Williamson D.H., Mellanby J., Krebs H.A. Enzymatic determination of D(-)-b-hydroxybutyric acid and acetoacetic acid in blood. J Biochem 1962, 82:90-96.
22. Govindaraju V., Young K., Maudsley A.A. Proton NMR chemical shifts and coupling constants for brain metabolites. NMR Biomed 2000, 13:129-153.
23. Wolf R., Klemisch H. Adaptation of an enzymatic fluorescence assay for l-glutamic acid decarboxylase. Anal Biochem 1991, 192:78-81.
24. Veech R.L. The therapeutic implications of ketone bodies: the effects of ketone bodies in pathological conditions: ketosis, ketogenic diet, redox states, insulin resistance, and mitochondrial metabolism. Prostaglandins Leukot Essent Fatty Acids 2004, 70:309-319.
25. Chen W., Gueron M. The inhibition of bovine heart hexokinase by 2-deoxy-d-glucose-6-phosphate: characterization by 31P NMR and metabolic implications. Biochimie 1992, 74:867-873.
26. Horton R.W., Meldrum B.S., Bachelard H.S. Enzymic and cerebral metabolic effects of 2-deoxy-d-glucose. J Neurochem 1973, 21:507-520.
27. Nakamoto Y., Nakayama S., Suzuki J. Cerebral uptake of [14C]deoxyglucose during the entire seizure and the recovery period in an El mouse. Epilepsy Res 1990, 5:43-48.
28. Verdonk C.A., Rizza R.A., Gerich J.E. Effects of plasma glucose concentration on glucose utilization and glucose clearance in normal man. Diabetes 1981, 30:535-537.
29. Hawkins R.A., Mans A.M., Davis D.W. Regional ketone body utilization by rat brain in starvation and diabetes. Am J Physiol 1986, 250:E169-E178.
30. Cornford E.M., Nguyen E.V., Landaw E.M. Acute upregulation of blood-brain barrier glucose transporter activity in seizures. Am J Physiol Heart Circ Physiol 2000, 279:H1346-H1354.
31. Yudkoff M., Daikhin Y., Melo T.M., Nissim I., Sonnewald U., Nissim I. The ketogenic diet and brain metabolism of amino acids: relationship to the anticonvulsant effect. Annu Rev Nutr 2007, 27:415-430.
32. Arias C., Valero H., Tapia R. Inhibition of brain glutamate decarboxylase activity is related to febrile seizures in rat pups. J Neurochem 1992, 58:369-373.
33. Veech R.L., Kashiwaya Y., Gates D.N., King M.T., Clarke K. The energetics of ion distribution: the origin of the resting electric potential of cells. IUBMB Life 2002, 54:241-252.
34. Veech R.L., Chance B., Kashiwaya Y., Lardy H.A., Cahill G.F. Ketone bodies, potential therapeutic uses. IUBMB Life 2001, 51:241-247.
35. Sato K., Kashiwaya Y., Keon C.A., Tsuchiya N., King M.T., Radda G.K., et al. Insulin, ketone bodies, and mitochondrial energy transduction. FASEB J 1995, 9:651-658.
36. Morris A.A. Cerebral ketone body metabolism. J Inherit Metab Dis 2005, 28:109-121.
37. Maalouf M., Rho J.M., Mattson M.P. The neuroprotective properties of calorie restriction, the ketogenic diet, and ketone bodies. Brain Res Rev 2009, 59:293-315.
38. McIlwain H., Tresize M.A. The glucose, glycogen and aerobic glycolysis of isolated cerebral tissues. Biochem J 1956, 63:250-257.
39. Huttenlocher P.R. Ketonemia and seizures: metabolic and anticonvulsant effects of two ketogenic diets in childhood epilepsy. Pediatr Res 1976, 10:536-540.